Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, IL

Clinical Trial Details


Research Study Summary

A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects with Castration Resistant Prostate Cancer That Have Received Prior Treatment with Docetaxel.


The purpose of this study is to examine the safety and effectiveness (how well the drug works) of treatment with radiotherapy followed by an investigational compound (a drug that is not currently approved by the United States Food and Drug Administration [FDA] or any other health authority), ipilimumab (also known as MDS-010 or BMS-734016). The effectiveness of ipilimumab will be determined by looking at:

  1. How many patients respond to treatment with radiotherapy followed by ipilimumab versus radiotherapy alone and how long the response lasts for each of these two treatments
  2. Survival time of the patients who receive radiotherapy followed by ipilimumab versus radiotherapy alone
  3. How safe radiotherapy followed by ipilimumab is, and what the side effects are
  4. How much a patient's level of pain changes when treated with radiotherapy followed by ipilimumab versus radiotherapy alone
  5. The health-related quality of life patients experience while on radiotherapy followed by ipilimumab versus radiotherapy alone

Please contact Alexian Brothers for more information on participation.

To Learn more

CW ID: 176857
Date Last Changed: July 22, 2013

Clinical Trial Snapshot

Overall Status
Facility Type


Alexian Brothers Hospital Network
800 Biesterfield Road
Elk Grove Village, IL 60007
Phone: 847-952-7164

View Map

Research Center Information:

Alexian Brothers Hospital Network

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.